Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist

被引:0
|
作者
Kershaw V. Patel
Ashish Sarraju
Ian J. Neeland
Darren K. McGuire
机构
[1] University of Texas Southwestern Medical Center,Division of Cardiology, Department of Internal Medicine
[2] Stanford University,Division of Cardiovascular Medicine and Cardiovascular Institute
来源
关键词
Atherosclerotic cardiovascular disease; Dipeptidyl peptidase-4 inhibitors; Glucagon-like peptide-1 receptor agonists; Heart failure; Type 2 diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study
    Santos-Pardo, Irene
    Lagerqvist, Bo
    Ritsinger, Viveca
    Witt, Nils
    Norhammar, Anna
    Nystrom, Thomas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 23 - 29
  • [32] Primary care management of type 2 diabetes: a comparison of the efficacy and safety of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
    Campos, Carlos
    Unger, Jeff
    POSTGRADUATE MEDICINE, 2021, 133 (08) : 843 - 853
  • [33] Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function
    Asuka Morita
    Eri Mukai
    Ayano Hiratsuka
    Tomozumi Takatani
    Toshihiko Iwanaga
    Eun Young Lee
    Takashi Miki
    Endocrine, 2016, 51 : 429 - 439
  • [34] Diuretic and Natriuretic Effects of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin: The Contribution of Glucagon-like Peptide-1
    Moroi, Masao
    Kubota, Tetsuya
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 66 (02) : 159 - 164
  • [35] Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function
    Morita, Asuka
    Mukai, Eri
    Hiratsuka, Ayano
    Takatani, Tomozumi
    Iwanaga, Toshihiko
    Lee, Eun Young
    Miki, Takashi
    ENDOCRINE, 2016, 51 (03) : 429 - 439
  • [36] Glucagon-Like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors, and Risk of Acute Pancreatitis: A Meta-analysis of Randomized Clinical Trial and Review of Literature
    Yakubov, Stanley
    Tin, Kevin
    Soe, EiEi P.
    Khodorskiy, Dmitriy O.
    Kadkhodayan, Kambiz
    Tsirlin, Yuriy
    Mayer, Ira E.
    Rahmani, Rabin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S10 - S10
  • [37] Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes
    Foresta, Andreana
    Ojeda-Fernandez, Luisa
    Macaluso, Giulia
    Roncaglioni, Maria Carla
    Tettamanti, Mauro
    Fortino, Ida
    Leoni, Olivia
    Genovese, Stefano
    Baviera, Marta
    CLINICAL THERAPEUTICS, 2023, 45 (04) : e115 - e126
  • [38] Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome
    Bouzas, Cristina
    Pastor, Rosario
    Garcia, Silvia
    Monserrat-Mesquida, Margalida
    Martinez-Gonzalez., Miguel Angel
    Salas-Salvado, Jordi
    Corella, Dolores
    Goday, Albert
    Martinez, J. Alfredo
    Alonso-Gomez, Angel M.
    Fernandez-Barcelo, Olga
    Vioque, Jesus
    Romaguera, Dora
    Lopez-Miranda, Jose
    Estruch, Ramon
    Tinahones, Francisco J.
    Lapetra, Jose
    Serra-Majema, Lluis
    Riquelme-Gallegop, Blanca
    Martin-Sanchez, Vicente
    Pinto, Xavier
    Delgado-Rodriguez, Miguel
    Matia, Pilar
    Vidal, Josep
    Cardenas-Salas, Jersy-Jair
    Daimiel, Lidia
    Ros, Emilio
    Toledo, Estefania
    Manzanares, Josep M.
    Gonzalez-Monge, Inmaculada
    Munoz, Miguel-Angel
    Martinez-Urbistondo, Diego
    Tojal-Sierra, Lucas
    Munoz-Bravoaf, Carlos
    Miralles-Gisbert, Salvador
    Martin, Marian
    Garcia-Rios, Antonio
    Castro-Barquero, Sara
    Fernandez-Garcia, Jose Carlos
    Santos-Lozano, Jose Manuel
    Basterra-Gortari, F. Javier
    Gutierrez-Carrasquilla, Liliana
    Guillem-Saiz, Patricia
    Satorres, Alba
    Abete, Itziar
    Sorto-Sanchez, Carolina
    Diez-Espino, Javier
    Babio, Nancy
    Fito, Montse
    Tur, Josep A.
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [39] Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes
    Senyigit, Abdulhalim
    Tabak, Omur
    Orbanoglu, Timur
    Karadag, Aytac
    Ugurlu, Serdal
    Uzun, Hafize
    Konukoglu, Dihlar
    CLINICAL AND INVESTIGATIVE MEDICINE, 2017, 40 (05): : E188 - E199
  • [40] The effect of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist in gestational diabetes mellitus: a systematic review
    Chen, Chengcong
    Huang, Ying
    Dong, Guoqing
    Zeng, Yongmei
    Zhou, Ziqiong
    GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (05) : 375 - 380